Eli Lilly plans $6.5 billion Texas manufacturing plant for obesity pill
A rendering of Eli Lilly’s manufacturing facility in Houston, Texas. Courtesy: Eli Lilly Eli Lilly on Tuesday said…
Study Finds Common Meds Leave Lasting Imprints on the Gut, Even Years After You Stop Taking Them
Medications may leave microbial “fingerprints” that last years after use, according to new research from the University of…
FDA moves to allow leucovorin as treatment for autism symptoms
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at…
Drew Weissman refutes RFK Jr. adviser’s claims about Covid shots
On Thursday and Friday, the Centers for Disease Control and Prevention held a meeting of its Advisory Committee…
Chemical Discovery Could Lower Prescription Drug Costs
A new sustainable method to produce pharmaceuticals could help to lower prescription drug costs in the U.S. This…
RFK Jr. vaccine panel Covid shot recommendations
Members of the Advisory Committee on Immunization Practices (ACIP) listen to a presentation about COVID-19 (coronavirus disease) during…
Semler Scientific pays $30 million to settle health care fraud claims
Semler Scientific will pay the Department of Justice nearly $30 million to settle health care fraud claims related…
Eli Lilly obesity pill beats Novo Nordisk drug in diabetes trial
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March…
FDA cracks down on prescription drug ads but lacks staff
WASHINGTON – In an unprecedented move, federal regulators published about 100 warning letters sent to pharmaceutical companies and health…
UK’s GSK announces $30 billion U.S. pharma investment amid Trump state visit
Rafael Henrique | Lightrocket | Getty Images Britain’s GSK on Wednesday became the latest pharmaceutical firm to commit…
Eli Lilly to build $5 billion Virginia manufacturing facility
Eli Lilly Biotechnology Center is shown in San Diego, California, March 1, 2023. Mike Blake | Reuters Eli…
Novo Nordisk tells staff to return to office full-time
The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…